H&B Group Cell Therapay

Disclosure

Medical Experts Visited Shangrao (International) Industry-Education-Research Base for Stem Cell & Regenerative Medicine

On April 16th, a dozen of medical experts from Shangrao Medical Association, led by Chairman Xiaogang Wang, visited Shangrao (International) Industry-Education-Research Base
Professor Zhongchao Han Accepted Times, Voice of China's Special Interview

In February 2014, President of Beijing Health & Biotech Corporation, Professor Zhongchao Han was invited to have a special interview with Times, Voice of China.
Stem Cell Industrialization of Health & Biotech Corporation Advances Rapidly

(Report from Beijing Star Daily) "This year we have three pressing businesses to pursue!" Shortly after 2014 Spring Festival, President of Beijing Health & Biotech, Professor Zhongchao Han

FDA Supports the Development of Mesenchymal Stem Cells as Medical Therapies

Scientists at the US Food and Drug Administration (FDA) are developing techniques to help identify which mesenchymal stem cells (MSCs) are most likely to be reliable t
Stem Cell Study Overcomes Major Hurdle in Organ Regeneration

According to Nature World News, University of Virginia School of Medicine researchers Bernard and Chris Thisse have turned embryonic stem cells into a fish embryo by manipulating certain biological signals. The study could advance organ re-generation using stem cells
Stem cell trials on tackling osteoarthritis may lead to treatment in five years

According to Irish news, researchers in Galway predict that stem cells could be used to treat osteoarthritis within five years, following successful initial clinical trials.

Health City

H&B hospital center was built, making full use of stem cell technology of H&B, in a similar mode as Mayo Clinic, featuring biological therapy and providing general medical service.